Exelixis
EXEL
#1730
Rank
A$15.41 B
Marketcap
$55.08
Share price
1.48%
Change (1 day)
74.57%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company